# BCLAF3

## Overview
BCLAF3 is a gene that encodes a protein belonging to the BCLAF1 and THRAP3 family, which is primarily involved in transcriptional regulation and RNA processing. The protein encoded by BCLAF3 is predominantly localized in the nucleus and plays a crucial role in modulating gene expression, thereby influencing cellular processes such as apoptosis, cell survival, and differentiation. Through its involvement in RNA processing, BCLAF3 contributes to the maturation and modification of RNA molecules, which are essential for accurate gene expression and the production of functional proteins. The protein's regulatory functions are vital for maintaining cellular homeostasis and ensuring proper cellular responses to environmental stimuli, impacting organismal development and tissue maintenance. Despite its recognized roles, the detailed mechanisms by which BCLAF3 influences transcription and RNA processing are still under investigation, underscoring its significance in cellular regulation and potential implications in various diseases (Bhat2022Integration; Guo2022Integrated; LaFlamme2024Diagnostic).

## Structure


## Function
BCLAF3, a member of the BCLAF1 and THRAP3 family, encodes a protein that plays a significant role in various cellular processes, particularly in transcriptional regulation and RNA processing. This protein is predominantly active in the nucleus, where it influences critical pathways related to cell survival and differentiation. By modulating gene expression, BCLAF3 contributes to the regulation of apoptosis, a process essential for maintaining cellular homeostasis and preventing uncontrolled cell proliferation. The protein's involvement in RNA processing suggests a role in the maturation and modification of RNA molecules, which are crucial for accurate gene expression and the production of functional proteins. Through these molecular activities, BCLAF3 impacts cell biology by ensuring proper cellular function and response to environmental cues, ultimately affecting organismal outcomes such as development and tissue maintenance. The precise mechanisms by which BCLAF3 exerts its effects on transcription and RNA processing remain an area of active research, highlighting its importance in understanding cellular regulation and potential implications in disease contexts.

## Clinical Significance
BCLAF3 has been implicated in various clinical conditions, particularly in the context of developmental and epileptic encephalopathies (uDEEs). A study identified a novel CGG repeat expansion in exon 1 of the BCLAF3 gene in a male proband with uDEE. This expansion was inherited from his unaffected mother, who exhibited skewed X-inactivation against the expanded allele, potentially explaining her lack of detectable DNA methylation abnormalities at this locus. The findings suggest that the loss of BCLAF3 in males could contribute to developmental and epileptic encephalopathies, highlighting the potential clinical significance of BCLAF3 gene mutations or expression alterations in these disorders (LaFlamme2024Diagnostic).

In cancer research, BCLAF3 has been identified as a gene that may regulate stemness and proliferation in gastric epithelial cells. A study using CRISPR/Cas9 technology found that BCLAF3, along with other genes, could function as a novel regulator of gastric epithelial differentiation, potentially impacting cancer development and progression (Bhat2022Integration).

Additionally, BCLAF3 has been associated with the Blautia genus, a gut microbial genus linked to Parkinson's disease. Although the specific role of BCLAF3 in Parkinson's disease is not detailed, it is suggested that BCLAF3 may be involved in pathways related to mitochondrial function, energy metabolism, and inflammatory response, which are critical in the pathogenesis of neurodegenerative diseases (Guo2022Integrated).


## References


[1. (Bhat2022Integration) Ajaz A. Bhat, Sabah Nisar, Soumi Mukherjee, Nirmalya Saha, Nageswari Yarravarapu, Saife N. Lone, Tariq Masoodi, Ravi Chauhan, Selma Maacha, Puneet Bagga, Punita Dhawan, Ammira Al-Shabeeb Akil, Wael El-Rifai, Shahab Uddin, Ravinder Reddy, Mayank Singh, Muzafar A. Macha, and Mohammad Haris. Integration of crispr/cas9 with artificial intelligence for improved cancer therapeutics. Journal of Translational Medicine, November 2022. URL: http://dx.doi.org/10.1186/s12967-022-03765-1, doi:10.1186/s12967-022-03765-1. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-022-03765-1)

[2. (Guo2022Integrated) Xingzhi Guo, Peng Tang, Chen Hou, Li Chong, Xin Zhang, Peng Liu, Li Chen, Yue Liu, Lina Zhang, and Rui Li. Integrated microbiome and host transcriptome profiles link parkinsonâ€™s disease to blautia genus: evidence from feces, blood, and brain. Frontiers in Microbiology, May 2022. URL: http://dx.doi.org/10.3389/fmicb.2022.875101, doi:10.3389/fmicb.2022.875101. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmicb.2022.875101)

[3. (LaFlamme2024Diagnostic) Christy W. LaFlamme, Cassandra Rastin, Soham Sengupta, Helen E. Pennington, Sophie J. Russ-Hall, Amy L. Schneider, Emily S. Bonkowski, Edith P. Almanza Fuerte, Talia J. Allan, Miranda Perez-Galey Zalusky, Joy Goffena, Sophia B. Gibson, Denis M. Nyaga, Nico Lieffering, Malavika Hebbar, Emily V. Walker, Daniel Darnell, Scott R. Olsen, Pandurang Kolekar, Mohamed Nadhir Djekidel, Wojciech Rosikiewicz, Haley McConkey, Jennifer Kerkhof, Michael A. Levy, Raissa Relator, Dorit Lev, Tally Lerman-Sagie, Kristen L. Park, Marielle Alders, Gerarda Cappuccio, Nicolas Chatron, Leigh Demain, David Genevieve, Gaetan Lesca, Tony Roscioli, Damien Sanlaville, Matthew L. Tedder, Sachin Gupta, Elizabeth A. Jones, Monika Weisz-Hubshman, Shamika Ketkar, Hongzheng Dai, Kim C. Worley, Jill A. Rosenfeld, Hsiao-Tuan Chao, Geoffrey Neale, Gemma L. Carvill, Zhaoming Wang, Samuel F. Berkovic, Lynette G. Sadleir, Danny E. Miller, Ingrid E. Scheffer, Bekim Sadikovic, and Heather C. Mefford. Diagnostic utility of dna methylation analysis in genetically unsolved pediatric epilepsies and chd2 episignature refinement. Nature Communications, August 2024. URL: http://dx.doi.org/10.1038/s41467-024-50159-6, doi:10.1038/s41467-024-50159-6. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-50159-6)